Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Biotech Acquisition Company/ 15-12G

SEC Filing · 15-12G

Biotech Acquisition Company

SEC Filing

Filed Feb 14, 2023Accepted Feb 14, 2023, 11:40 AM ESTCIK 1825413Accession 0001213900-23-011557
View company →Permanent SEC source ↗
Share

Company context

Historical securities (3)
BIOTOTC · EQUITY · Historical · closed Feb 2, 2023BIOTUNASDAQ · UNIT · Historical · closed Feb 2, 2023BIOTWNASDAQ · WARRANT · Historical · closed Feb 2, 2023

Recent company filings

  1. SC 13G/A filingFeb 14, 2023
  2. SC 13G/A filingFeb 13, 2023
  3. 25-NSE filingFeb 2, 2023
  4. 8-K filingFeb 2, 2023
  5. 8-K filingJan 25, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗